---
title: "Synopsys, Inc. $SNPS Stake Lifted by Montrusco Bolton Investments Inc."
description: "Montrusco Bolton Investments Inc. increased its stake in Synopsys, Inc. (NASDAQ:SNPS) by 40% in Q2, now owning 416,518 shares valued at $209.34 million. Other institutional investors, including Vangua"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/260882097.md"
published_at: "2025-10-13T10:57:19.000Z"
---

# Synopsys, Inc. $SNPS Stake Lifted by Montrusco Bolton Investments Inc.

> Montrusco Bolton Investments Inc. increased its stake in Synopsys, Inc. (NASDAQ:SNPS) by 40% in Q2, now owning 416,518 shares valued at $209.34 million. Other institutional investors, including Vanguard and Pictet, also raised their stakes. CEO Sassine Ghazi sold 11,366 shares, reducing his position by 13.7%. Synopsys shares are down 9.4%, with a recent price of $438.92, and reported Q3 earnings of $2.30 per share, missing estimates. The company has set FY 2025 guidance at 12.760-12.800 EPS.

Montrusco Bolton Investments Inc. increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 40.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 416,518 shares of the semiconductor company's stock after buying an additional 118,961 shares during the quarter. Synopsys comprises approximately 2.3% of Montrusco Bolton Investments Inc.'s holdings, making the stock its 19th largest position. Montrusco Bolton Investments Inc. owned 0.27% of Synopsys worth $209,340,000 at the end of the most recent reporting period.

-   MarketBeat Week in Review – 09/15 - 09/19

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of Synopsys by 2.4% in the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company's stock worth $6,359,747,000 after purchasing an additional 346,994 shares in the last quarter. Pictet Asset Management Holding SA grew its stake in shares of Synopsys by 38.3% in the first quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company's stock worth $1,043,518,000 after purchasing an additional 673,837 shares in the last quarter. Ameriprise Financial Inc. grew its stake in shares of Synopsys by 6.6% in the first quarter. Ameriprise Financial Inc. now owns 2,013,380 shares of the semiconductor company's stock worth $863,500,000 after purchasing an additional 125,199 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Synopsys by 20.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company's stock worth $778,928,000 after purchasing an additional 305,489 shares in the last quarter. Finally, Alliancebernstein L.P. grew its stake in shares of Synopsys by 22.2% in the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company's stock worth $739,857,000 after purchasing an additional 313,218 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

## Insider Transactions at Synopsys

In other news, CEO Sassine Ghazi sold 11,366 shares of the firm's stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the completion of the sale, the chief executive officer directly owned 71,615 shares of the company's stock, valued at $42,181,951.15. This trade represents a 13.70% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the firm's stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $500.90, for a total value of $4,945,385.70. Following the sale, the chief accounting officer directly owned 20,520 shares of the company's stock, valued at $10,278,468. This trade represents a 32.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 30,894 shares of company stock valued at $16,760,783 over the last 90 days. Company insiders own 0.62% of the company's stock.

## Synopsys Stock Down 9.4%

-   Wall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall

Shares of Synopsys stock opened at $438.92 on Monday. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The stock has a 50-day moving average price of $544.01 and a 200 day moving average price of $510.99. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. The company has a market cap of $81.53 billion, a P/E ratio of 34.45, a P/E/G ratio of 4.84 and a beta of 1.10.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing analysts' consensus estimates of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The firm had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.77 billion. During the same period last year, the business earned $3.43 earnings per share. The firm's revenue for the quarter was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, analysts expect that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

## Wall Street Analysts Forecast Growth

-   3 AI Infrastructure Stocks With Strong Growth, Not Hype

Several research analysts have recently issued reports on SNPS shares. BNP Paribas started coverage on Synopsys in a research note on Thursday, October 2nd. They issued an "underperform" rating and a $425.00 price target for the company. Bank of America reaffirmed an "underperform" rating and set a $525.00 target price (down previously from $625.00) on shares of Synopsys in a research note on Wednesday, September 10th. Baird R W cut Synopsys from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, September 10th. Morgan Stanley decreased their target price on Synopsys from $715.00 to $510.00 and set an "overweight" rating for the company in a research note on Thursday, September 11th. Finally, KeyCorp reduced their target price on Synopsys from $660.00 to $590.00 and set an "overweight" rating for the company in a report on Wednesday, September 10th. Eleven analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $575.31.

**View Our Latest Stock Analysis on Synopsys**

## Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

## See Also

-   Five stocks we like better than Synopsys
-   What is a SEC Filing?
-   Microsoft 365 Premium Marks the Next Phase of AI Monetization
-   Low PE Growth Stocks: Unlocking Investment Opportunities
-   Could Target’s Week of Discounts Come Full Circle for Investors?
-   What is a Dividend King?
-   3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings

**Want to see what other hedge funds are holding SNPS?** Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

*This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.*

## Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### Related Stocks

- [SNPS.US - Synopsys](https://longbridge.com/en/quote/SNPS.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| GF Fund Management CO. LTD. Buys 3,294 Shares of Synopsys, Inc. $SNPS | GF Fund Management CO. LTD. increased its stake in Synopsys, Inc. by 3.9% in Q3, acquiring 3,294 shares, bringing its to | [Link](https://longbridge.com/en/news/276001587.md) |
| Synopsys (SNPS) Valuation Check As Institutions Add, Ansys Deal Closes And AI Partnerships Support Record Revenue | Recent SEC filings reveal that major investors like PRIMECAP, Morgan Stanley, and BlackRock have increased their stakes  | [Link](https://longbridge.com/en/news/275999637.md) |
| Synopsys Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Synopsys, Inc. - SNPS | Kahn Swick & Foti, LLC has initiated an investigation into Synopsys, Inc. (SNPS) following a lawsuit filed by Cangrade,  | [Link](https://longbridge.com/en/news/276021618.md) |
| 18,411 Shares in Synopsys, Inc. $SNPS Acquired by Kinsale Capital Group Inc. | Kinsale Capital Group Inc. acquired 18,411 shares of Synopsys, Inc. (NASDAQ:SNPS) in Q3, valued at approximately $9.08 m | [Link](https://longbridge.com/en/news/275227202.md) |
| Alps Advisors Inc. Sells 106,865 Shares of Global Medical REIT Inc. $GMRE | Alps Advisors Inc. has reduced its stake in Global Medical REIT Inc. (NYSE: GMRE) by 80%, selling 106,865 shares in Q3,  | [Link](https://longbridge.com/en/news/275726503.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
